DENTSPLY SIRONA Inc. (XRAY), headquartered in Charlotte, North Carolina, is a leading global manufacturer of professional dental products and technologies. The company is committed to enabling dental professionals to provide world-class oral health care to patients around the world.
DENTSPLY SIRONA's professional dental solutions range from traditional dental products to advanced digital technologies. These include dental implants, orthodontic appliances, endodontic instruments and materials, bone grafting materials, dental consumables, dental equipment, dental lab products, CAD/CAM systems, imaging systems, treatment centers and more.
XRAY serves dental professionals in over 120 countries and maintains a robust distribution network across the globe. The company was established in 2016 through a merger between DENTSPLY International Inc. and Sirona Dental Systems Inc. This merger united two of the strongest brands in dental technologies, creating the world's largest manufacturer of professional dental solutions.
DENTSPLY SIRONA maintains a strong commitment to innovation and invests heavily in research and development. Such investments have resulted in various industry-leading solutions that have revolutionized the practice of dentistry, including CEREC CAD/CAM restorative systems that have advanced digital dentistry.
Moreover, the company is committed to enhancing dentists' clinical skills and the professional success of dental practices through a broad range of educational programs. These programs are offered through its DENTSPLY SIRONA Academy, which is recognized globally for high-quality dental education.
One of the main guiding principles of DENTSPLY SIRONA is the promotion of better, safer, and faster dental care. This commitment to quality and patient care is reflected in the company's vision and mission to empower dental professionals to improve patients' oral health worldwide. The company is also committed to maintaining high ethical standards and responsible business practices.
That said, DENTSPLY SIRONA continues to set the pace in the global dental industry with its cutting-edge technology and solutions, and dedication to professional education. Its strong market presence, continuous innovation, and ability to meet dental professionals’ diverse needs make XRAY a preferred choice for dental solutions worldwide. In summary, DENTSPLY SIRONA plays a significant role in shaping the future of dentistry, making it an industry leader and a transformative force in oral health care.
In terms of financial performance, DENTSPLY SIRONA Inc. is publicly traded under the ticker symbol XRAY on the NASDAQ Global Select Market. It continues to demonstrate robust financial performance, highlighting the strength and stability of its business model.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article analyzes the Q2 performance of several dental equipment and technology stocks, highlighting Dentsply Sirona (XRAY), Envista (NVST), Align Technology (ALGN), and Henry Schein (HSIC). It details their revenue growth, performance against analyst estimates, and stock price reactions, noting that the sector experienced strong Q2 revenues but subsequent stock price declines. The piece also touches on broader market shifts, including concerns over AI and geopolitics impacting investor focus.
Bank of America Corp DE has acquired 2.92 million shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY), valued at approximately $31 million, marking a new 1.47% stake in the company. Institutional investors collectively hold 95.7% of DENTSPLY SIRONA's stock, with several firms increasing or initiating positions. Despite analysts maintaining a "Hold" rating with a target price of $13.31, the medical instruments supplier recently beat quarterly earnings estimates but experienced a 4.1% year-over-year revenue decline.
Squarepoint Ops LLC significantly reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by selling 431,734 shares, retaining 55,600 shares valued at approximately $590,000. Despite beating EPS estimates, the medical instruments supplier's revenue declined year-over-year. Analysts currently hold a consensus "Hold" rating for XRAY with an average target price of $13.31.
DENTSPLY SIRONA (NASDAQ:XRAY) stock recently hit a new 52-week low of $9.36. Despite exceeding quarterly EPS and revenue estimates, the company experienced a 4.1% year-over-year revenue decline and a negative net margin. Analyst sentiment is mixed, with a consensus "Hold" rating and a target price of $13.31, while institutional investors hold a significant majority of the stock.
Amundi significantly reduced its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 85.6% in the second quarter, selling over 240,000 shares. Despite this, institutional investors collectively own approximately 95.7% of the company's stock, with several other funds either initiating or increasing their positions. Analysts currently have a consensus "Hold" rating on XRAY with an average price target of $13.54, even though the company recently beat EPS and revenue estimates while experiencing a year-over-year revenue decline.
Virginia Retirement Systems acquired 225,700 shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, valued at approximately $2.4 million. This new holding represents about 0.11% of the company, which continues to see high institutional ownership at 95.7%. Despite a recent revenue decline, DENTSPLY SIRONA beat quarterly EPS estimates, and analysts maintain a consensus "Hold" rating with a target price of $13.54.
UBS Asset Management Americas LLC has reduced its stake in DENTSPLY SIRONA Inc. by selling 182,661 shares, retaining 452,599 shares valued at approximately $4.8 million. Despite beating earnings and revenue estimates in the last quarter, the company's stock has an average "Hold" rating from analysts with a consensus price target of $13.54, trading near its one-year low. Institutional investors collectively own 95.7% of the medical instruments supplier.
DENTSPLY SIRONA (XRAY) has returned to profitability in Q2 2026 despite a 4.1% year-over-year decline in net sales. The company's shares have shown choppy performance, with short-term gains contrasting with significant long-term losses. Analysts view the stock as 14.7% undervalued, with a fair value of $13.40, driven by expectations of expanding digital dentistry platforms and improved margins.
The Manufacturers Life Insurance Company has acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY), purchasing 184,321 shares valued at approximately $1.96 million. Institutional investors collectively own 95.7% of the company, while insiders recently bought 35,160 shares worth about $351,179. Despite mixed analyst sentiment and a "Hold" rating, the company exceeded recent quarterly EPS and revenue expectations.